Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CNA | CB |
|---|---|---|
| Price | $45.63 | $329.88 |
| Change today | ▲ 1.67% | ▲ 1.42% |
| Market cap | $12.35B | $127.27B |
| Return, 3 months | – | -5.9% |
| Return, year to date | – | +6.7% |
| Return, 1 year | – | +18.7% |
| P/E (TTM) | 10.1 | 11.7 |
| P/B | 1.1 | 1.7 |
| P/E percentile vs own 5y | – | 48th |
| Dividend yield | 4.12% | 1.19% |
| Revenue growth (YoY, latest qtr) | – | +7.2% |
| Net profit growth (YoY) | – | -3.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 18.0% |
| Return on equity | – | 15.5% |
| Analyst target vs. price | +7.4% | +13.4% |
| Analyst buy share | 0% | 39% |
| RSI (14) | – | 37 |
| 30-day volatility | – | 14.9% |
| Max drawdown, 1 year | – | -9.4% |
| Trend read | – | Leaning bearish |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
